GENABIO

Since its founding, Genabio has surpassed $100 million in sales revenue and is currently in a phase of rapid growth. We have made strategic investments in ARCpoint Labs, which operates more than 150 branches across the United States. Genabio is advancing through initial public offerings (IPOs) and pursuing mergers and acquisitions (M&A) with high-quality technology companies globally. Our ambition is to become the world's leading provider of self-testing solutions, delivering precise, user-friendly, and cost-effective health diagnostics to individuals worldwide within the next 5-10 years... Genabio Diagnostics Inc. is a global leader in at-home self-testing products, offering a comprehensive portfolio that includes infectious disease tests, women's health self-tests, rapid drug abuse tests, and metabolic health monitoring products.

Also known as: Genabio Diagnostics, Genabio Diagnostics Inc.

Primary location: Bedford United States